DAKO S0809抗体稀释液antibody diluent

Intended use
For In Vitro Diagnostic Use. 
This product is intended for the preparation of primary and secondary antibody dilutions and negative control reagents for use in 
immunohistochemical (IHC) staining procedures. In the demonstration of tissue antigens by IHC, optimal staining performance usually 
requires the use of diluted antibodies (1). 
Refer to Dako’s General Instructions for Immunohistochemical Staining or the detection system instructions of IHC procedures for: 
1) Principle of Procedure, 2) Materials Required, Not Supplied, 3) Storage, 4) Specimen Preparation, 5) Staining Procedure, 6) Quality 
Control, 7) Troubleshooting, 8) Interpretation of Staining, 9) General Limitations. 

DAKO S0809抗体稀释液antibody diluent

Reagent provided 
Tris-HCI buffer containing stabilizing protein and 0.015 mol/L sodium azide. 
Precautions 
1. For professional users. 
2. This product contains sodium azide (NaN3), a chemical highly toxic in pure form. At product concentrations, though not classified as 
hazardous, build-ups of NaN3 may react with lead and copper plumbing to form highly explosive metal azides. Upon disposal, flush with 
large volumes of water to prevent azide build-up in plumbing. 
3. Minimize microbial contamination of reagents or increase in nonspecific staining may occur. 
4. Wear appropriate Personal Protective Equipment to avoid contact with eyes and skin. 
5. Unused solution should be disposed of according to local, State and Federal regulations. 
Storage 
Store at 2–8 °C. Do not freeze

DAKO抗体是丹麦的著名抗体生产商，提供世界上质量zui稳定，zui为经典的抗体。其主要产品涉及免疫化学、流式细胞，免疫组织化学，原位杂交，微生物检验等。DAKO的不同显色系统，Envision，LSAB和免疫细胞化学的CAS，GenpointTM和用于分子病理学的PNA=ISH试剂盒，和用于ELISA的AMPAKTM/AmpliQ是其在生物化学研究中的革新产品 。

2012年5月17日，安捷伦科技公司（纽约证交所：A）22亿美元收购安捷伦收购丹麦癌症诊断公司Dako（丹科）。